RI · State guide
Fact-checked by Dr. J. Adam, MD on . See our fact-checking policy.
Best GLP-1 telehealth providers serving Rhode Island: NexLife availability, Wegovy and Zepbound access, compounded options, pricing, and Rhode Island-specific notes.
| Provider | Status in RI | Starting price |
|---|---|---|
| NexLife (editor's pick) | ✓ Available | $145–$165/mo |
| Henry Meds | ✓ Available | $297/mo |
| Hims | ✓ Available | $145–$165/mo |
| Ro | ✓ Available | $145/mo |
| Mochi Health | ✓ Available | $79 + Rx |
| ZappyHealth | ✓ Available | $169/mo |
All FDA-approved GLP-1 medications are legally available in Rhode Island with a prescription:
Coverage for Wegovy and Zepbound varies by carrier and employer plan. Most commercial plans require prior authorization. State Medicaid coverage varies. See our insurance hub for carrier-specific details.
Most major GLP-1 telehealth providers serve Rhode Island, including NexLife (editor's pick, published pricing), Henry Meds, Hims, Ro, Mochi Health, and ZappyHealth. See our full provider rankings.
Yes, both Wegovy and Zepbound are FDA-approved and available in Rhode Island through telehealth or in-person prescribers, subject to insurance coverage and prior authorization.
Yes, compounded semaglutide is available through telehealth providers serving Rhode Island. NexLife (editor pick) offers $145–$165/mo flat-rate compounded sema in Rhode Island.
Compounded GLP-1 programs serving Rhode Island typically range $169–$499/month, depending on medication, dose, and provider. Brand-name Wegovy and Zepbound list prices range $1,086–$1,349/month, often reduced significantly with insurance prior auth.
State Medicaid coverage for weight-loss GLP-1s varies. Some state Medicaid programs cover Wegovy with criteria; many do not. Check Rhode Island Medicaid drug formulary directly.